Baxiva is a biotechnology startup dedicated to developing next-generation glycoconjugate vaccines aimed at preventing infections caused by Gram-negative bacterial pathogens. Our lead vaccine candidate targets Escherichia coli, the leading cause of urinary tract infections worldwide and a significant contributor to antimicrobial resistance. Based on cutting-edge science and operating in Schlieren on ETH Zurich’s Hönggerberg campus, Baxiva offers a unique opportunity to engage in high-impact science with genuine clinical potential.
As an in vivo associate at Baxiva, you will play a crucial role in our in vivo team. This hands-on position involves conducting mouse experiments in our animal facility to evaluate various elements of our vaccine. You will also be engaged in assay development, focusing on the immunological performance of vaccine components. This role will be primarily based at Hönggerberg within the Mucosal Immunology research group, collaborating closely with the vaccine development team in Schlieren.
Your main responsibilities will include:
We are looking for an individual who is curious, reliable, and committed to delivering high-quality results while eager to grow with us. You should enjoy solving complex problems collaboratively to create a meaningful impact in the real world.
You bring:
We are a small, agile team of motivated scientists working in a friendly, collaborative environment where everyone contributes their experience and expertise. We believe that scientific productivity thrives in an atmosphere of open exchange, trust, and collaboration. We are dedicated to supporting the personal and professional growth of each team member.
We look forward to receiving your online application using the form below. Please note that only applications matching the job profile will be considered.
Location : Zürich ETH-Hönggerberg
Country : Switzerland